We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

128 hedge funds and large institutions have $447M invested in Array Biopharma Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

51% less call options, than puts

Call options by funds: $396K | Put options by funds: $809K

Holders
128
Holders Change
+128
Holders Change %
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
128
Increased
Reduced
Closed
Calls
$396K
Puts
$809K
Net Calls
-$413K
Net Calls Change
-$413K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
US Bancorp
101
US Bancorp
Minnesota
$79K +$94.1K +17,500 New
Comerica Bank
102
Comerica Bank
Texas
$62K +$72.6K +13,503 New
SCM
103
Stevens Capital Management
Pennsylvania
$58K +$69.2K +12,867 New
Prudential Financial
104
Prudential Financial
New Jersey
$50K +$59.5K +11,057 New
CAM
105
Capstone Asset Management
Texas
$49K +$57.5K +10,687 New
WAM
106
World Asset Management
Michigan
$49K +$57.6K +10,709 New
DIA
107
Denver Investment Advisors
Colorado
$49K +$58K +10,788 New
NTCOC
108
Northern Trust Company of Connecticut
Connecticut
$46K +$53.9K +10,023 New
ILIM
109
Irish Life Investment Managers
Ireland
$45.2K +$53.8K +10,000 New
FTIOP
110
Fiduciary Trust International of Pennsylvania
Pennsylvania
$45K +$53.8K +10,000 New
LTFS
111
Ladenburg Thalmann Financial Services
Florida
$45K +$53.8K +10,000 New
SBCM
112
Silver Bridge Capital Management
Massachusetts
$45K +$53.8K +10,000 New
SB
113
Suntrust Banks
Georgia
$45K +$54.4K +10,114 New
FMT
114
First Mercantile Trust
Tennessee
$42K +$49.2K +9,152 New
Teacher Retirement System of Texas
115
Teacher Retirement System of Texas
Texas
$34K +$40.6K +7,547 New
Ameriprise
116
Ameriprise
Minnesota
$33K +$39.1K +7,279 New
ST
117
Stifel Trust
Missouri
$30K +$35K +6,500 New
PNC Financial Services Group
118
PNC Financial Services Group
Pennsylvania
$29K +$33.9K +6,300 New
HMS
119
Hanseatic Management Services
New Mexico
$22K +$26K +4,837 New
BlackRock
120
BlackRock
New York
$17K +$19.9K +3,700 New
SFPIA
121
Stevens First Principles Investment Advisors
California
$16K +$18.8K +3,500 New
BG
122
BlackRock Group
United Kingdom
$10K +$11.7K +2,169 New
Citigroup
123
Citigroup
New York
$8K +$9.53K +1,771 New
Creative Planning
124
Creative Planning
Kansas
$4K +$4.3K +800 New
TRCT
125
Tower Research Capital (TRC)
New York
$1K +$1.43K +266 New

ARRY Hedge Fund Activity: Q2 2013 in Review

128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q2 2013, worth a combined $447M.

Buyers outnumbered sellers: 128 funds opened new ARRY positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Array Biopharma Inc (ARRY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $447M of Array Biopharma Inc stock for Q2 2013.
  • 128 funds opened new Array Biopharma Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.